Trials / Completed
CompletedNCT02290600
Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Sansum Diabetes Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this 12 week feasibility study is to see how much more accurate a continuous glucose monitor (CGM) might be in individuals with type 1 diabetes if the investigators personalize sensor calibrations to the user, based on previous wear.
Detailed description
The purpose of this 12 week study is to see how much more accurate a continuous glucose monitor (CGM) might be if we personalize the sensor calibration algorithm for each individual. The calibration algorithm is a mathematical calculation built into the CGM. Currently, the CGM asks for a regular blood test (finger stick) measurement twice a day in order to make its calibration algorithm more accurate. Our goal is to keep refining the calculating ability so that it will provide personalized blood sugar control throughout the day for each individual using the sensor with the CGM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous Glucose Monitor | CGM sensor calibration individualization |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-10-01
- Completion
- 2016-12-01
- First posted
- 2014-11-14
- Last updated
- 2018-07-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02290600. Inclusion in this directory is not an endorsement.